SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics (NASDAQ:MBRX), announced today that Dr. Paul Laikind, president and chief executive officer of Metabasis, will present at the Sixth Annual JMP Securities Research Conference at the Ritz-Carlton Hotel in San Francisco, California. Dr. Laikind is scheduled to present on Tuesday, May 22, 2007 at 4:00 p.m. Pacific Time, and is expected to provide an overview of the Company’s progress and discuss product candidates in clinical development.
